Cargando…

Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer

BACKGROUND: The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables su...

Descripción completa

Detalles Bibliográficos
Autores principales: Diessner, Joachim, Wischnewsky, Manfred, Stüber, Tanja, Stein, Roland, Krockenberger, Mathias, Häusler, Sebastian, Janni, Wolfgang, Kreienberg, Rolf, Blettner, Maria, Schwentner, Lukas, Wöckel, Achim, Bartmann, Catharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865990/
https://www.ncbi.nlm.nih.gov/pubmed/27175930
http://dx.doi.org/10.1186/s12885-016-2345-7
_version_ 1782431866702266368
author Diessner, Joachim
Wischnewsky, Manfred
Stüber, Tanja
Stein, Roland
Krockenberger, Mathias
Häusler, Sebastian
Janni, Wolfgang
Kreienberg, Rolf
Blettner, Maria
Schwentner, Lukas
Wöckel, Achim
Bartmann, Catharina
author_facet Diessner, Joachim
Wischnewsky, Manfred
Stüber, Tanja
Stein, Roland
Krockenberger, Mathias
Häusler, Sebastian
Janni, Wolfgang
Kreienberg, Rolf
Blettner, Maria
Schwentner, Lukas
Wöckel, Achim
Bartmann, Catharina
author_sort Diessner, Joachim
collection PubMed
description BACKGROUND: The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables such as primary tumour stage, biological and histological subtype, age at primary diagnosis, tumour size, the number of affected lymph nodes as well as grading influence the development of bone-only metastases. METHODS: This retrospective German multicentre study is based on the BRENDA collective and included 9625 patients with primary breast cancer recruited from 1992 to 2008. In this analysis, we investigated a subgroup of 226 patients with bone-only metastases. Association between bone-only relapse and clinico-pathological risk factors was assessed in multivariate models using the tree-building algorithms “exhausted CHAID (Chi-square Automatic Interaction Detectors)” and CART(Classification and Regression Tree), as well as radial basis function networks (RBF-net), feedforward multilayer perceptron networks (MLP) and logistic regression. RESULTS: Multivariate analysis demonstrated that breast cancer subtypes have the strongest influence on the development of bone-only metastases (χ2 = 28). 29.9 % of patients with luminal A or luminal B (ABC-patients) and 11.4 % with triple negative BC (TNBC) or HER2-overexpressing tumours had bone-only metastases (p < 0.001). Five different mathematical models confirmed this correlation. The second important risk factor is the age at primary diagnosis. Moreover, BC subcategories influence the overall survival from date of metastatic disease of patients with bone-only metastases. Patients with bone-only metastases and TNBC (p < 0.001; HR = 7.47 (95 % CI: 3.52–15.87) or HER2 overexpressing BC (p = 0.007; HR = 3.04 (95 % CI: 1.36–6.80) have the worst outcome compared to patients with luminal A or luminal B tumours and bone-only metastases. CONCLUSION: The bottom line of different mathematical models is the prior importance of subcategories of breast cancer and the age at primary diagnosis for the appearance of osseous metastases. The primary tumour stage, histological subtype, tumour size, the number of affected lymph nodes, grading and NPI seem to have only a minor influence on the development of bone-only metastases.
format Online
Article
Text
id pubmed-4865990
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48659902016-05-14 Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer Diessner, Joachim Wischnewsky, Manfred Stüber, Tanja Stein, Roland Krockenberger, Mathias Häusler, Sebastian Janni, Wolfgang Kreienberg, Rolf Blettner, Maria Schwentner, Lukas Wöckel, Achim Bartmann, Catharina BMC Cancer Research Article BACKGROUND: The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables such as primary tumour stage, biological and histological subtype, age at primary diagnosis, tumour size, the number of affected lymph nodes as well as grading influence the development of bone-only metastases. METHODS: This retrospective German multicentre study is based on the BRENDA collective and included 9625 patients with primary breast cancer recruited from 1992 to 2008. In this analysis, we investigated a subgroup of 226 patients with bone-only metastases. Association between bone-only relapse and clinico-pathological risk factors was assessed in multivariate models using the tree-building algorithms “exhausted CHAID (Chi-square Automatic Interaction Detectors)” and CART(Classification and Regression Tree), as well as radial basis function networks (RBF-net), feedforward multilayer perceptron networks (MLP) and logistic regression. RESULTS: Multivariate analysis demonstrated that breast cancer subtypes have the strongest influence on the development of bone-only metastases (χ2 = 28). 29.9 % of patients with luminal A or luminal B (ABC-patients) and 11.4 % with triple negative BC (TNBC) or HER2-overexpressing tumours had bone-only metastases (p < 0.001). Five different mathematical models confirmed this correlation. The second important risk factor is the age at primary diagnosis. Moreover, BC subcategories influence the overall survival from date of metastatic disease of patients with bone-only metastases. Patients with bone-only metastases and TNBC (p < 0.001; HR = 7.47 (95 % CI: 3.52–15.87) or HER2 overexpressing BC (p = 0.007; HR = 3.04 (95 % CI: 1.36–6.80) have the worst outcome compared to patients with luminal A or luminal B tumours and bone-only metastases. CONCLUSION: The bottom line of different mathematical models is the prior importance of subcategories of breast cancer and the age at primary diagnosis for the appearance of osseous metastases. The primary tumour stage, histological subtype, tumour size, the number of affected lymph nodes, grading and NPI seem to have only a minor influence on the development of bone-only metastases. BioMed Central 2016-05-12 /pmc/articles/PMC4865990/ /pubmed/27175930 http://dx.doi.org/10.1186/s12885-016-2345-7 Text en © Diessner et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Diessner, Joachim
Wischnewsky, Manfred
Stüber, Tanja
Stein, Roland
Krockenberger, Mathias
Häusler, Sebastian
Janni, Wolfgang
Kreienberg, Rolf
Blettner, Maria
Schwentner, Lukas
Wöckel, Achim
Bartmann, Catharina
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
title Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
title_full Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
title_fullStr Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
title_full_unstemmed Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
title_short Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
title_sort evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865990/
https://www.ncbi.nlm.nih.gov/pubmed/27175930
http://dx.doi.org/10.1186/s12885-016-2345-7
work_keys_str_mv AT diessnerjoachim evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT wischnewskymanfred evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT stubertanja evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT steinroland evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT krockenbergermathias evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT hauslersebastian evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT janniwolfgang evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT kreienbergrolf evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT blettnermaria evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT schwentnerlukas evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT wockelachim evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer
AT bartmanncatharina evaluationofclinicalparametersinfluencingthedevelopmentofbonemetastasisinbreastcancer